We are
AION Labs

The future of pharma

Our mission
is to bring brilliant
minds together

Who dare
to think the
unthinkable

And uncover
innovative
ways

To transform
the future

Of drug discovery & development

About

AION Labs

AION Labs is a first-of-its-kind alliance of global pharma and technology leaders and investors that have come together with one clear mission: to create and adopt gateway AI and computational technologies that will transform the process of drug discovery and development for the betterment of human health.

 

We invite brilliant inventors, scientists and technologists to solve the biggest R&D challenges of today’s pharma with the support and guidance of years of accumulated know-how, data, and experience of our partners.

 

Backed by our partners’ wealth of knowledge and fresh multidisciplinary approach, we combine the ingenuity, agility and innovative instinct of Israel’s start-up ecosystem to create and develop strong companies with disruptive technology which will pave the way to the future of pharma.

 

Our unique venture creation process eliminates the gap between technologies and markets with our built in product-market innovation model.

Join the AION Labs Challenge

Founders

Calling all researchers!

Apply to our new bootcamp challenge where you’ll have the opportunity to demonstrate your skills, ideas and expertise in addressing pharma’s next big challenge, and we’ll provide first-hand access to the finest tools and expert guidance available today. Join us as architects of modern science.

Build the future with AION Labs

Start-Ups

We are open to hearing your clever ideas!

If your company has come up with a viable AI or computational-based biotech solution, we’d love to hear from you. AION Labs is here to fulfil our shared purpose and help push your brilliant ideas forward. Come and meet us.

Challenges

Challenge #01

October 2021Founders chosen, team in formation
Artificial Intelligence for Antibody Design
Closed

Challenge #02

December 2021 - Closing 13 February 2022
Artificial intelligence for clinical trial readiness of drug candidates
Closed

Challenge #03

February 2022Founders chosen, team in formation
Design and Optimization of
Antibodies for Targeted Therapies
Closed

Management

Mati Gill

CEO

Dr. Yair Benita

CTO

Einav Daniel

Finance Director

Moran Mamluk

Administrative Operations Manager

Partners

Board of directors

Ohad Goldberg

President AZ Israel

Investment commitee

Dr. James Weatherall

VP AI R&D

Alliance & R&D Principals

Sharon Ein-Gal

External AI Innovation

Nina Mian

Head of R&D Data Science Learning & Development

Board of directors

Dr. Joern Peter-Halle

Chief Strategy Officer

Investment commitee

Dr. Noga Yerushalmi

Head of Israel Bio
Incubator

Alliance & R&D Principals

Regine Shevach

MD R&D Israel

Board of directors

Dr. Anthony Barry

External Scouting
and Innovation

Investment commitee

Dr. David Von Schack

Head Molecular Systems
Immunology

Alliance & R&D Principals

Tamara Mansfield

Global Innovation Lead

Board of directors

Eli Shani

EVP Global
Marketing & Portfolio

Investment commitee

Dr. Steffen Nock

SVP Head of Global
R&D Ops & Biosimilars

Alliance & R&D Principals

Shiri Netser

Director, Business Development

Dr. Dana Bar-On

Sr. Director, Head of Global R&D Academic Affairs & Networks

Board of directors

Guy Spigelman

EMEA Lead Healthcare
& Life Sciences Startups

Investment commitee

Dan Sheeran

Director of Healthcare
& Lifesciences

Board of directors

Dr. Yuval Cabilly

Co-founder
& Managing Partner

Investment commitee

Ido Zairi

Co-founder &
Managing Partner

Strategic partners

Dr. Christian Tidona

Founder & Managing Director,
BioMed X Institute

Latest news

February 15, 2022

AIThority: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

December 13, 2021

AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

October 19, 2021

AION Labs Launches First Global Call for Application: Artificial Intelligence for Antibody Design

October 20, 2021

Newly-Launched AION Forms Startup in Israel

October 19, 2021

A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.

October 13, 2021

Pharma consortium, AWS and IBF open Israel AI therapeutics lab

October 13, 2021

AWS joins pharma and biotech leaders in launching AION Labs to transform therapeutics

December 28, 2020

Pfizer Pharmaceutical, AstraZeneca and Amazon to Build New Innovation Laboratory in Israel

October 22, 2021

An Israeli Lab Tests A Unique Way Of Collaborating and Scaling AI

November 9, 2021

Driving innovation in pharma AI

October 18, 2021

AION Labs committed to industry best practices business ethics and compliance of IFPMA

October 13, 2021

Pharma Leaders companies join hands with Amazon on new Israel-based AI Innovation Lab

October 21, 2021

Call for Application:
AION Labs spots 'unique opportunity' for AI-driven antibody discovery

December 13, 2021

AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

January 19, 2022

Executives Discuss AION Labs, a First-of-its-Kind Innovation Lab Focused on AI Technologies

January 4, 2022

AI providing the edge against cancer?

February 14, 2022

AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

May 2, 2022

Interview with AION Labs CTO: How AL/ML are transforming drug discovery and development

Contact us

AION Labs | info@aionlabs.com | www.aionlabs.com | Connect with us on

AION Labs
info@aionlabs.com | Connect with us

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.